certolizumab pegol
Cimzia Receives New Indication for Moderate to Severe Plaque Psoriasis
The FDA approved a new indication for Cimzia to treat moderate to severe plaque psoriasis in adults.
MAY 30, 2018
Label Change for Cimzia: Negligible Mother-Child Transfer
Some women with chronic inflammatory diseases experience persistent moderate to high disease activity during ...
MARCH 22, 2018
Load more